Published in Journal of gastroenterology and hepatology
At current prices, velpatasvir-based pan-genotypic regimen is cost-effective for HCV treatment in India where generic drugs are available. A reduction in the prices of pan-genotypic regimen has the potential to make its use cost-saving, while simplifying treatment in community-level programs aimed at HCV elimination.
Published in Journal of gastroenterology and hepatology
The results confirmed that shikonin attenuated liver fibrosis by downregulating the TGF-β1/Smads pathway and inhibiting autophagy.
Published in Journal of gastroenterology and hepatology
Pathological diagnosis of GLP by invasive endoscopy is still intractable, even at a late stage. Positive results can be obtained even in small or distant lymph nodes.
Published in Journal of gastroenterology and hepatology
Selection of an optimal meatus insertion tract by an anterior meatuscopy causes lesser nasal pain, epistaxis, and post-procedural side effects in nasal anesthesia and UT-EGD than the conventional sniff test.
Published in Journal of gastroenterology and hepatology
Published in Journal of gastroenterology and hepatology
Published in Journal of gastroenterology and hepatology
Our results indicated that rs12309362 (G > A), rs9970827 (A > G) in DHSs, and elevated expression of CEBPB were associated with a decreased risk of HCC. These results may contribute us to understand the function of regulatory DNA sequences in HCC development.
Published in Journal of gastroenterology and hepatology
Published in Journal of gastroenterology and hepatology
Although the antiviral effect was slightly lower in patients with severe fibrosis compared with those without, treatment with daclatasvir and asunaprevir is basically an effective and well-tolerable treatment in these populations.
Published in Journal of gastroenterology and hepatology
